Curtis Lockshin insider trades
Open-market stock purchases and sales by Curtis Lockshin, Director at Phio Pharmaceuticals Corp, from SEC Form 4 filings since Feb 5, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 5, 2026 | PHIO Phio Pharmaceuticals Corp | Bought (not open market) | — |
Companies traded
- PHIO Phio Pharmaceuticals Corp: other filings, last Feb 5, 2026
- XBIO Xenetic Biosciences, Inc: other filings, last Dec 11, 2023
- RXII RXi Pharmaceuticals Corp: 1 buy, last Aug 1, 2018
- CDXC.OB ChromaDex Corp: other filings, last Dec 21, 2012
- SRNE Sorrento Therapeutics, Inc: other filings, last Jul 20, 2012